Carbutamide
Chemical compound
- A10BB06 (WHO)
- 4-amino-N-(butylcarbamoyl)benzenesulfonamide
- 339-43-5
Y
- 9564
- 9189
N
- E3K8P4869P
- ChEMBL448570 Y
- DTXSID8022741
- Interactive image
- O=S(=O)(c1ccc(N)cc1)NC(=O)NCCCC
InChI
- InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15)N
- Key:VDTNNGKXZGSZIP-UHFFFAOYSA-NN
N
Y (what is this?) (verify)Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.
It is classified as first-generation.[1]
It was patented in 1953 and approved for medical use in 1956.[2]
See also
- Hellmuth Kleinsorge (1920-2001) German medical doctor
References
- ^ Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). "Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds". Diabetes Research and Clinical Practice. 8 (2): 109–114. doi:10.1016/0168-8227(90)90020-T. PMID 2106423.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 449. ISBN 9783527607495.
- v
- t
- e
Oral diabetes medication, insulins and insulin analogs, and other drugs used in diabetes (A10)
| |||||||||||
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
